Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDVor Biopharma Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 2 | -$0.42 | -$0.42 | -$0.42 |
| Q2 2024 | 3 | -$0.40 | -$0.40 | -$0.40 |
| Q3 2024 | 5 | -$0.40 | -$0.21 | -$0.34 |
| Q1 2025 | 3 | -$0.36 | -$0.27 | -$0.32 |
| Q2 2025 | 2 | -$0.33 | -$0.33 | -$0.33 |
| Q3 2025 | 2 | -$0.34 | -$0.34 | -$0.34 |
| Q4 2025 | 2 | -$0.36 | -$0.36 | -$0.36 |
Vor Biopharma Inc. Earnings Date And Information
Vor Biopharma Inc. last posted its earnings results on Thursday, November 7th, 2024. The company reported $-0.4 earnings per share for the quarter, missing analysts' consensus estimates of $-0.4 by $0. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Vor Biopharma Inc. has generated $-2 earnings per share over the last year ($-1.75 diluted earnings per share) and currently has a price-to-earnings ratio of -0.53. Vor Biopharma Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 18th, 2025 based on prior year's report dates.
Vor Biopharma Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/07/2024 | Q3 2024 | -$0.40 | -$0.40 | 0 | $0 | $0 |
| 08/08/2024 | Q2 2024 | -$0.41 | -$0.41 | 0 | $0 | $0 |
| 08/08/2024 | Q1 2024 | -$0.41 | -$0.45 | -0.04 | $0 | |
| 03/20/2024 | Q4 2023 | -$0.49 | -$0.39 | 0.1 | $12.23 M | |
| 11/07/2023 | Q3 2023 | -$0.46 | -$0.49 | -0.03 | $0 | |
| 08/10/2023 | Q2 2023 | -$0.42 | -$0.45 | -0.03 | $0 | |
| 05/11/2023 | Q1 2023 | -$0.38 | -$0.40 | -0.02 | $0 | |
| 03/23/2023 | Q4 2022 | -$0.56 | -$0.49 | 0.07 | $0 | |
| 11/10/2022 | Q3 2022 | -$0.60 | -$0.62 | -0.02 | $0 | |
| 08/11/2022 | Q2 2022 | -$0.67 | -$0.57 | 0.1 | $0 | |
| 05/12/2022 | Q1 2022 | -$0.54 | -$0.61 | -0.07 | $0 | |
| 03/14/2022 | Q4 2021 | -$0.55 | -$0.49 | 0.06 | $0 | |
| 11/10/2021 | Q3 2021 | -$0.58 | -$0.50 | 0.08 | $0 | |
| 08/09/2021 | Q2 2021 | -$0.47 | -$0.50 | -0.03 | $0 | |
| 05/06/2021 | Q1 2021 | -$0.83 | -$0.62 | 0.21 | $0 | |
| 03/25/2021 | Q4 2020 | -$4.40 | -$0.70 | 3.7 | $0 | |
| 09/29/2020 | Q3 2020 | -$0.97 | $0 | |||
| 06/29/2020 | Q2 2020 | -$0.66 | $0 | |||
| 03/30/2020 | Q1 2020 | -$0.64 | $0 | |||
| 12/30/2019 | Q4 2019 | -$0.32 | $0 |
Vor Biopharma Inc. Earnings: FAQ's
When is Vor Biopharma Inc.'s earnings date?
Vor Biopharma Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 18th, 2025 based off last year's report dates.
How can I listen to Vor Biopharma Inc.'s earnings conference
call?
The conference call for Vor Biopharma Inc.'s latest earnings report can be listened to online.
How can I read Vor Biopharma Inc.'s conference call transcript?
The conference call transcript for Vor Biopharma Inc.'s latest earnings report can be read online.
How much profit does Vor Biopharma Inc. generate each year?
Vor Biopharma Inc. (:VOR) has a recorded net income of $0. Vor Biopharma Inc. has generated $-1.75 earnings per share over the last four quarters.
What is Vor Biopharma Inc.'s price-to-earnings ratio?
Vor Biopharma Inc. (:VOR) has a price-to-earnings ratio of -0.53 and price/earnings-to-growth ratio is -0.1.